MRK vs TMO
By Alex · Tickerpine
Merck & Co., Inc. vs Thermo Fisher Scientific Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | TMO |
|---|---|---|
| Price | $128.66 | $513.03 |
| Market cap | $317.77B | $190.65B |
| P/E ratio | 36.2 | 28.2 |
| ROE | 18.94% | 13.52% |
| Profit margin | 13.59% | 15.15% |
| Revenue growth | 4.90% | 6.20% |
| Dividend yield | 2.64% | 0.37% |
| Beta | 0.22 | 0.87 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs TMO in plain English
- MRK is the bigger company — about 1.7× the market cap of TMO.
- TMO is cheaper on earnings (P/E 28.2 vs 36.2).
- MRK earns a higher return on equity (19% vs 14%).
- TMO is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.64% vs 0.37%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.